Cytosorbents Ratios (2010-2026) | CTSO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	77.46%	74.77%	71.04%	73.79%	58.21%	44.60%	61.31%	57.73%	63.89%	63.64%	61.27%	76.46%	73.55%	61.02%	68.35%	71.13%	70.85%	70.28%	73.68%	69.16%
EBT Margin (Quarter)	-38.90%	-65.64%	-93.14%	-103.16%	-128.06%	-150.42%	-19.79%	-77.53%	-65.31%	-104.34%	167.57%	-67.73%	-46.86%	-32.14%	26.94%	-16.94%	-44.00%	-37.65%	-70.46%	-44.01%
EBIT Margin (Quarter)	-40.96%	-55.39%	-88.68%	-89.64%	-98.37%	-111.17%	-67.69%	-83.51%	-69.62%	-83.42%	-108.54%	-51.80%	-40.38%	-56.08%	-37.10%	-44.54%	-37.59%	-30.17%	92.68%	-34.34%
EBITDA Margin (Quarter)	-40.96%	-55.39%	-88.68%	-89.64%	-98.37%	-111.17%	-67.69%	-83.51%	-69.62%	-83.42%	-108.54%	-51.80%	-40.38%	-56.08%	-37.10%	-44.54%	-37.59%	-30.17%	92.68%	-34.34%
Operating Margin (Quarter)	-40.96%	-55.39%	-88.68%	-89.64%	-98.37%	-111.17%	-67.69%	-83.51%	-69.62%	-83.42%	-108.54%	-51.80%	-40.38%	-56.08%	-37.10%	-44.54%	-37.59%	-30.17%	92.68%	-34.34%
Net Margin (Quarter)	-38.90%	-65.64%	-86.32%	-103.16%	-128.06%	-150.42%	-8.16%	-77.53%	-65.31%	-104.34%	-67.31%	-70.73%	-48.56%	-32.14%	-82.69%	-16.94%	20.25%	-33.42%	-59.53%	-57.86%
FCF Margin (Quarter)	-13.37%	-42.35%	-84.70%	-101.59%	-88.98%	-83.66%	-57.71%	-38.29%	-71.37%	-60.71%	-75.02%	-54.23%	-54.42%	-30.36%	-23.32%	-39.73%	-16.09%	-27.35%	-53.42%	-13.23%
Efficiency
Inventory Average (Quarter)	3.40M	4.11M	4.65M	5.11M	5.21M	4.26M	3.50M	2.59M	1.89M	2.51M	3.18M	3.56M	4.03M	3.78M	2.99M	2.88M	3.36M	3.86M	4.64M	4.88M
Assets Average (Quarter)	92.84M	96.63M	92.29M	86.40M	77.24M	66.74M	62.75M	60.35M	54.95M	50.01M	50.27M	50.01M	50.25M	50.62M	47.59M	49.08M	49.39M	46.87M	44.97M	42.37M
Equity Average (Quarter)	75.82M	72.50M	66.59M	59.00M	51.49M	43.35M	37.26M	32.66M	27.20M	21.64M	21.15M	21.55M	18.53M	15.40M	12.24M	12.83M	13.06M	10.30M	7.46M	4.05M
Invested Capital (Quarter)	74.38M	70.61M	62.58M	55.43M	47.56M	39.14M	35.37M	34.95M	29.48M	23.84M	28.52M	22.13M	17.43M	13.38M	11.11M	14.54M	11.59M	24.02M	5.90M	8.84M
Asset Utilization Ratio (Quarter)	0.49	0.46	0.47	0.48	0.49	0.54	0.55	0.59	0.66	0.74	0.72	0.72	0.70	0.69	0.75	0.72	0.73	0.79	0.82	0.88
Leverage & Solvency
Debt to Equity (Quarter)							0.14		0.21	0.27	0.21	0.23	0.78	1.03	1.26	0.98	1.24	1.61	2.82	7.73
Debt Ratio (Quarter)							0.08		0.10	0.11	0.10	0.09	0.26	0.29	0.30	0.28	0.30	0.32	0.38	0.42
Equity Ratio (Quarter)	0.76	0.74	0.70	0.67	0.67	0.63	0.56	0.52	0.47	0.40	0.44	0.42	0.33	0.28	0.23	0.29	0.24	0.20	0.13	0.05
Valuation
Enterprise Value (Quarter)	-65.61M	-61.04M	-52.14M	-43.02M	-30.16M	-22.55M	-22.14M	-19.05M	-1.70M	-8.40M	-14.13M	-8.61M	-8.46M	-5.70M	-8.28M	-11.59M	-10.20M	-7.54M	-6.25M	-4.80M
Return Ratios
Return on Sales (Quarter)	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	0.00%	-0.01%	-0.01%	-0.01%	0.02%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%
Return on Capital Employed (Quarter)	-15.08%	-18.49%	-28.94%	-38.60%	-46.66%	-61.34%	-59.43%	-62.13%	-66.32%	-73.45%	-86.14%	-75.02%	-61.53%	-53.07%	-43.56%	-39.86%	-39.77%	-37.43%	-5.12%	-53.34%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%			-0.01%	-0.01%	-0.01%		-0.02%	-0.01%	-0.01%		-0.01%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	-0.02%	-0.04%

Research Tools

Cytosorbents Ratios (2010-2026) | CTSO

Create an account

Sign In

Reset Password